Rabbit Polyclonal RGL2 antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Fragment Protein within Human RGL2 aa 100-350.
View Alternative Names
RAB2L, RGL2, Ral guanine nucleotide dissociation stimulator-like 2, RalGDS-like 2, RalGDS-like factor, Ras-associated protein RAB2L
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-RGL2 antibody (AB137600)
Immunofluorescent analysis of paraformaldehyde-fixed HeLa cells labelling RGL2 with ab137600 at 1/200 dilution. Lower panel merged with DNA probe.
- WB
Unknown
Western blot - Anti-RGL2 antibody (AB137600)
7.5% SDS PAGE
All lanes:
Western blot - Anti-RGL2 antibody (ab137600) at 1/500 dilution
All lanes:
Raji whole cell lysate at 30 µg
Predicted band size: 84 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Ral Guanine Nucleotide Dissociation Stimulator-Like 2 acts as a guanine nucleotide exchange factor (GEF) which activates Ral GTPases by facilitating the exchange of GDP for GTP. The protein is a member of the RAS subfamily GEFs and contributes greatly to the formation of signaling complexes that affect multiple cellular processes. RGL2 interacts with other proteins to modulate cell growth cytoskeletal organization and vesicle trafficking.
Pathways
RGL2 plays a role in the MAPK/ERK signaling pathway and the PI3K/Akt pathway. These pathways are critical for cell proliferation and survival. It works closely with RalA and RalB proteins acting as a mediator in transmitting signals from receptor tyrosine kinases. Through this interaction RGL2 contributes to the regulation of cell cycle progression and apoptosis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in oncology 12:858598 PubMed35321435
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of international medical research 48:300060519871407 PubMed32727237
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com